Full Press Release Details
SAN RAFAEL, Calif. , Aug. 10, 2020 /PRNewswire/ -- BioMarin Pharmaceutical Inc. (NASDAQ: BMRN ) today announced that Jeff Ajer , Executive Vice President and Chief Commercial Officer, and Brian Mueller , Executive Vice President, Chief Financial Officer will participate in the 2020 Wedbush PacGrow Healthcare Virtual Conference on August 11, 2020 at 10:55am ET and Henry Fuchs , M.D., President, Worldwide Research & Development and Brian Mueller , Executive Vice President, Chief Financial Officer, will participate in the Canaccord Genuity 40th Annual Growth Conference on August 13, 2020 at 1:00pm ET . An audio webcast of the presentations will be available live. You can access the webcast at: https://investors.biomarin.com/ . An archived version of the remarks will also be available through the Company's website for a limited time following the conference.
BioMarin is a global biotechnology company that develops and commercializes innovative therapies for people with serious and life-threatening rare disorders. The company's portfolio consists of six commercialized products and multiple clinical and pre-clinical product candidates.
For additional information, please visit www.biomarin.com . Information on BioMarin's website is not incorporated by reference into this press release.
| Contacts: | |
| Investors | Media |
| Traci McCarty | Debra Charlesworth |
| BioMarin Pharmaceutical Inc. | BioMarin Pharmaceutical Inc. |
| (415) 455-7558 | (415) 455-7451 |